In January 2020 researchers from The Netherlands published the results of their study to assess the use of low-dose aspirin amongst women with an increased risk pre-eclampsia. It has been shown that low-dose aspirin usage during pregnancy reduces the risk of pre-eclampsia. A total of 865 women were involved in the study and followed using web-based surveys. Rates of low-dose aspirin usage amongst women with an increased risk of pre-eclampsia risk were assessed. Three hundred and six women had a predicted increased risk of pre-eclampsia. Results showed that use of low-dose aspirin was higher for women receiving risk-based care as compared to care-as-usual. An analysis revealed that there was higher daily low-dose aspirin usage when the woman’s predicted risk and/or women’s concerns regarding pre-eclampsia was higher. Most reported reasons for non- or incomplete usage were an unawareness that low dose aspirin could reduce the risk of pre-eclampsia, concerns of potential adverse effects and doubts regarding the benefits. The researchers concluded that future research was required regarding potential factors that may improve the usage of low-dose aspirin during pregnancy.
van Montfort P et al. Low-dose-aspirin usage among women with an increased pre-eclampsia risk: a prospective cohort study. Acta Obstet Gynecol Scand. 2020 Jan 18. [Epub ahead of print]
Where lifestyle meets science
